
Beam Therapeutics - Breaking new ground to advance science …
Cambridge, MA is home to our bio-tech hub, where we constantly innovate and challenge ourselves to break new ground. We are located at: 238 Main Street, Cambridge, MA 02142. © …
What are the primary areas of focus for Beam Therapeutics?
Mar 20, 2025 · Beam Therapeutics’ research and development efforts are centrally focused on advancing gene editing technologies, with base editing being the cornerstone of its innovation …
Beam Therapeutics Announces Progress in Hematology and
Jan 13, 2025 · Beam’s second core area of focus seeks to create single-course gene editing therapies for genetic diseases by delivering base editors through intravenous infusion of LNPs, …
Beam Therapeutics SWOT Analysis & Strategic Plan 2025-Q4
Oct 4, 2025 · Beam Therapeutics is creating a new class of genetic medicines. Using ultra-precise base editing technology, it develops potential one-time cures for severe diseases by correcting …
Beam Therapeutics (BEAM): The Next Frontier in Biotech - Nasdaq
Oct 18, 2024 · Beam Therapeutics (BEAM) is at the forefront of gene editing, a revolutionary medical technology that is drawing significant interest from investors worldwide due to its …
Beam Therapeutics (BEAM) Announces Acquisition of an Early …
Jul 16, 2025 · Beam Therapeutics Inc. (NASDAQ:BEAM) is a biotechnology company that develops precision genetic medicines through base editing, a technology that allows efficient …
Science | Beam Therapeutics
In 2017, Beam Therapeutics was founded by gene editing pioneers with a goal of creating precision genetic medicines with base editing, a technology discovered at Harvard University …
Beam Therapeutics lays off staff, adjusts research focus
Oct 26, 2023 · Instead, Beam will focus on its leading therapeutic candidate, a base editing therapy for sickle cell disease (SCD), and a second therapy that delivers hematopoietic stem …
Beam Therapeutics Inc. (BEAM): history, ownership, mission, how …
Beam Therapeutics defines its purpose through a clear mission focused on pioneering genetic medicines, underpinned by core values that guide its operations and culture.
Beam Therapeutics: A High-Growth Stock Opportunity
Nov 19, 2024 · Beam Therapeutics Inc. is making waves in the world of gene editing with its unique base editing technology. This innovative approach allows for precise changes at the …